NHS Framework Agreement for Branded medicines - National

A Contract Award Notice
by NHS ENGLAND

Source
Contracts Finder
Type
Framework (Products)
Duration
2 year
Value
£526M
Sector
HEALTH
Published
14 Jun 2022
Delivery
01 May 2022 to 30 Apr 2024
Deadline
09 Dec 2021 13:00

Related Terms

Location

Geochart for 1 buyers and 86 suppliers

1 buyer

86 suppliers

Description

NHS Framework Agreement for Branded medicines - National FIND A TENDER (FTS) Reference number FTS-003607 Offer reference number CM/PHR/21/5643 NHS Framework Agreement for Branded Medicines - National Period of Framework: 1 May 2022 to 30 April 2024

Award Detail

1 Thornton & Ross (Huddersfield)
  • Value: £526,000,000
2 Selective Supplies (London)
  • Value: £526,000,000
3 Teva (Wakefield)
  • Value: £526,000,000
4 Wockhardt (Wrexham)
  • Value: £526,000,000
5 Martindale Pharma (None)
  • Value: £526,000,000
6 Thea Pharmaceuticals (Newcastle)
  • Value: £526,000,000
7 Merck Sharpe & Dohme (London)
  • Value: £526,000,000
8 Norgine Pharmaceuticals (Uxbridge)
  • Value: £526,000,000
9 Kent Pharma (Heathrow)
  • Value: £526,000,000
10 Tillomed Laboratories (Luton)
  • Value: £526,000,000
11 Bayer (Reading)
  • Value: £526,000,000
12 Roche Products (Garden City)
  • Value: £526,000,000
13 Dexcel Pharma (Daventry)
  • Value: £526,000,000
14 Mylan (Barnet)
  • Value: £526,000,000
15 Abbvie (Maidenhead)
  • Value: £526,000,000
16 Rosemont Pharmaceuticals (Leeds)
  • Value: £526,000,000
17 Recordati Rare Diseases (Bracknell)
  • Value: £526,000,000
18 Intrapharm Laboratories (Maidenhead)
  • Value: £526,000,000
19 Accord (None)
  • Value: £526,000,000
20 Ranbaxy (Hayes)
  • Value: £526,000,000
21 Glaxosmithkline (London)
  • Value: £526,000,000
22 Drugsrus (Northwood)
  • Value: £526,000,000
23 Sandoz (Camberley)
  • Value: £526,000,000
24 Ennogen Healthcare (Dartford)
  • Value: £526,000,000
25 Mibe Pharma (London)
  • Value: £526,000,000
26 Cambridge Healthcare Supplies (None)
  • Value: £526,000,000
27 Morningside Pharmaeuticals (Northampton)
  • Value: £526,000,000
28 Pfizer (None)
  • Value: £526,000,000
29 DR Falk Pharma (None)
  • Value: £526,000,000
30 Mercury Pharmaceuticals (London)
  • Value: £526,000,000
31 Fresenius Kabi (None)
  • Value: £526,000,000
32 Novo Nordisk (Gatwick)
  • Value: £526,000,000
33 Neon Healthcare (None)
  • Value: £526,000,000
34 Tillotts Pharma (None)
  • Value: £526,000,000
35 Napp Pharmaceuticals (Cambridge)
  • Value: £526,000,000
36 Takeda (London)
  • Value: £526,000,000
37 Day Lewis Medical (None)
  • Value: £526,000,000
38 B Braun Medical (Sheffield)
  • Value: £526,000,000
39 Aguettant (Bristol)
  • Value: £526,000,000
40 Ferring Pharmaceuticals (West Drayton)
  • Value: £526,000,000
41 Aventis Pharma (Reading)
  • Value: £526,000,000
42 Astrazeneca (Luton)
  • Value: £526,000,000
43 Baxter Healthcare (None)
  • Value: £526,000,000
44 Colonis Pharma (London)
  • Value: £526,000,000
45 Eli Lilly (Basingstoke)
  • Value: £526,000,000
46 Reckitt Benckiser (None)
  • Value: £526,000,000
47 Crescent Pharma (None)
  • Value: £526,000,000
48 CST Pharma (Walsall)
  • Value: £526,000,000
49 Janssen Cilag (Highwycombe)
  • Value: £526,000,000
50 Grunenthal (Stockenchurch)
  • Value: £526,000,000
51 Aspire Pharma (None)
  • Value: £526,000,000
52 Flynn Pharma (None)
  • Value: £526,000,000
53 Chiesi (Manchester)
  • Value: £526,000,000
54 Ferndale Pharmaceuticals (Wetherby)
  • Value: £526,000,000
55 Logixx Pharma (None)
  • Value: £526,000,000
56 Clinigen Healthcare (Burton on Trent)
  • Value: £526,000,000
57 Aop Orphan (None)
  • Value: £526,000,000
58 Aspen Pharmacare (None)
  • Value: £526,000,000
59 Glenmark Pharmaceuticals Europe (Watford)
  • Value: £526,000,000
60 Organon Pharmaceuticals (London)
  • Value: £526,000,000
61 Zentiva Pharma (London)
  • Value: £526,000,000
62 Orphalan (Birkirkara)
  • Value: £526,000,000
63 Fontus Health (Walsall)
  • Value: £526,000,000
64 Univar Solutions (Rotterdam)
  • Value: £526,000,000
65 Roma Pharmaceuticals (Burton upon Trent)
  • Value: £526,000,000
66 Alliance Pharmaceuticals (None)
  • Value: £526,000,000
67 Lupin Healthcare (None)
  • Value: £526,000,000
68 Cenote Pharma (None)
  • Value: £526,000,000
69 Kyowa Kirin (Galashiels)
  • Value: £526,000,000
70 Biofrontera Pharma (Leverkusen)
  • Value: £526,000,000
71 Pharmacosmos (Reading)
  • Value: £526,000,000
72 Pari (London)
  • Value: £526,000,000
73 Stirling Anglian Pharmaceuticals (Glasgow)
  • Value: £526,000,000
74 Strides Pharma (Watford)
  • Value: £526,000,000
75 Karo Pharma (Stockholm)
  • Value: £526,000,000
76 Rayner Surgical Group (Worthing)
  • Value: £526,000,000
77 Galen (Craigavon)
  • Value: £526,000,000
78 Oralieve (Luton)
  • Value: £526,000,000
79 Typharm (Norwich)
  • Value: £526,000,000
80 Opella Healthcare (None)
  • Value: £526,000,000
81 Torrent Pharma (Crawley)
  • Value: £526,000,000
82 Necessity Supplies (Northolt)
  • Value: £526,000,000
83 Focus Pharmaceuticals (London)
  • Value: £526,000,000
84 Eisai (Hatfield)
  • Value: £526,000,000
85 Cipla (None)
  • Value: £526,000,000
86 Ever Pharma (Banbury)
  • Value: £526,000,000

CPV Codes

  • 33600000 - Pharmaceutical products

Indicators

  • Contract is suitable for SMEs.

Other Information

03. Framework Agreement and Terms and Conditions https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/8d000000IVWq/hNT.ARwdbil... 220523 Branded Transparency Award Schedule https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/8d000000IVSo/BZksXQbnsrQ... Document No.10 - Participating Authorities https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/8d000000IVSj/q1mLlf7JKUs... 211103 - V2 -FTS-003607 Contract Notice https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/8d000000IVY3/kN307qwOfip... Parties Appointed to the Framework - CM_PHR_21_5643 National Proprietary Medicines Framework - Copy https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/8d000000IVf9/I7VC.i1Cj4c...

Reference

  • CF-0839600D0O000000rwimUAA1
  • CF 8c8bd7e5-2e25-4cff-829e-94321875e89e

Domains